Annual report

Period2020-01-01 → 2020-12-31

Filed2023-03-03

StandardJapan GAAP

ConsolidatedYes

Data checks24 of 24 passed

Key figures · 147

Metric	Value	Period	Scope	Source row
Revenue	¥77.7bn	2020-01-01 → 2020-12-31	Cons.	Net sales
Revenue	¥75.4bn	2019-01-01 → 2019-12-31	Cons.	Net sales
Revenue	¥77.2bn	2018-01-01 → 2018-12-31^d	Cons.	Net sales (5-year summary)
Revenue	¥78.7bn	2017-01-01 → 2017-12-31^d	Cons.	Net sales (5-year summary)
Revenue	¥79.2bn	2016-01-01 → 2016-12-31^d	Cons.	Net sales (5-year summary)
Operating income	¥2.2bn	2020-01-01 → 2020-12-31	Cons.	Operating income
Operating income	¥1.8bn	2019-01-01 → 2019-12-31	Cons.	Operating income
Ordinary income	¥2.2bn	2020-01-01 → 2020-12-31	Cons.	Ordinary income
Ordinary income	¥1.7bn	2019-01-01 → 2019-12-31	Cons.	Ordinary income
Ordinary income	¥1.6bn	2018-01-01 → 2018-12-31^d	Cons.	Ordinary income loss (5-year summary)
Ordinary income	¥1.9bn	2017-01-01 → 2017-12-31^d	Cons.	Ordinary income loss (5-year summary)
Ordinary income	¥1.9bn	2016-01-01 → 2016-12-31^d	Cons.	Ordinary income loss (5-year summary)
Profit before tax	¥1.8bn	2020-01-01 → 2020-12-31	Cons.	Income before income taxes
Profit before tax	¥1.6bn	2019-01-01 → 2019-12-31	Cons.	Income before income taxes
Net income (owners)	¥1.1bn	2020-01-01 → 2020-12-31	Cons.	Profit loss attributable to owners of parent
Net income (owners)	¥1.1bn	2019-01-01 → 2019-12-31	Cons.	Profit loss attributable to owners of parent
Net income (owners)	¥469m	2018-01-01 → 2018-12-31^d	Cons.	Profit loss attributable to owners of parent (5-year summary)
Net income (owners)	¥1.3bn	2017-01-01 → 2017-12-31^d	Cons.	Profit loss attributable to owners of parent (5-year summary)
Net income (owners)	¥610m	2016-01-01 → 2016-12-31^d	Cons.	Profit loss attributable to owners of parent (5-year summary)
Net income	¥1.2bn	2020-01-01 → 2020-12-31	Cons.	Profit loss
Net income	¥1.2bn	2019-01-01 → 2019-12-31	Cons.	Profit loss
Total assets	¥51.7bn	at 2020-12-31	Cons.	Assets
Total assets	¥52.6bn	at 2019-12-31	Cons.	Assets
Total assets	¥53.3bn	at 2018-12-31^d	Cons.	Total assets (5-year summary)
Total assets	¥54.5bn	at 2017-12-31^d	Cons.	Total assets (5-year summary)
Total assets	¥52.3bn	at 2016-12-31^d	Cons.	Total assets (5-year summary)
Total liabilities	¥29.6bn	at 2020-12-31	Cons.	Liabilities
Total liabilities	¥30.7bn	at 2019-12-31	Cons.	Liabilities
Net assets / equity	¥22.1bn	at 2020-12-31	Cons.	Net assets
Net assets / equity	¥21.8bn	at 2019-12-31	Cons.	Net assets
Net assets / equity	¥21.2bn	at 2018-12-31^d	Cons.	Net assets
Net assets / equity	¥21.3bn	at 2017-12-31^d	Cons.	Net assets (5-year summary)
Net assets / equity	¥20.9bn	at 2016-12-31^d	Cons.	Net assets (5-year summary)
Cash and deposits	¥915m	at 2020-12-31	Cons.	Cash and deposits
Cash and deposits	¥1.2bn	at 2019-12-31	Cons.	Cash and deposits
Cash & equivalents	¥910m	at 2020-12-31	Cons.	Cash and cash equivalents
Cash & equivalents	¥1.2bn	at 2019-12-31	Cons.	Cash and cash equivalents
Cash & equivalents	¥1.2bn	at 2018-12-31^d	Cons.	Cash and cash equivalents
Cash & equivalents	¥1.3bn	at 2017-12-31^d	Cons.	Cash and cash equivalents (5-year summary)
Cash & equivalents	¥1.9bn	at 2016-12-31^d	Cons.	Cash and cash equivalents (5-year summary)
Operating cash flow	¥4.8bn	2020-01-01 → 2020-12-31	Cons.	Net cash provided by used in operating activities
Operating cash flow	¥3.9bn	2019-01-01 → 2019-12-31	Cons.	Net cash provided by used in operating activities
Operating cash flow	¥3.7bn	2018-01-01 → 2018-12-31^d	Cons.	Net cash provided by used in operating activities (5-year summary)
Operating cash flow	¥3.1bn	2017-01-01 → 2017-12-31^d	Cons.	Net cash provided by used in operating activities (5-year summary)
Operating cash flow	¥3.2bn	2016-01-01 → 2016-12-31^d	Cons.	Net cash provided by used in operating activities (5-year summary)
Investing cash flow	−¥3.5bn	2020-01-01 → 2020-12-31	Cons.	Net cash provided by used in investment activities
Investing cash flow	−¥2.3bn	2019-01-01 → 2019-12-31	Cons.	Net cash provided by used in investment activities
Investing cash flow	−¥3.0bn	2018-01-01 → 2018-12-31^d	Cons.	Net cash provided by used in investing activities (5-year summary)
Investing cash flow	−¥2.0bn	2017-01-01 → 2017-12-31^d	Cons.	Net cash provided by used in investing activities (5-year summary)
Investing cash flow	−¥535m	2016-01-01 → 2016-12-31^d	Cons.	Net cash provided by used in investing activities (5-year summary)
Financing cash flow	−¥1.5bn	2020-01-01 → 2020-12-31	Cons.	Net cash provided by used in financing activities
Financing cash flow	−¥1.7bn	2019-01-01 → 2019-12-31	Cons.	Net cash provided by used in financing activities
Financing cash flow	−¥828m	2018-01-01 → 2018-12-31^d	Cons.	Net cash provided by used in financing activities (5-year summary)
Financing cash flow	−¥1.7bn	2017-01-01 → 2017-12-31^d	Cons.	Net cash provided by used in financing activities (5-year summary)
Financing cash flow	−¥2.5bn	2016-01-01 → 2016-12-31^d	Cons.	Net cash provided by used in financing activities (5-year summary)
EPS (basic)	¥19.26	2020-01-01 → 2020-12-31	Cons.	Basic earnings loss per share (5-year summary)
EPS (basic)	¥18.28	2019-01-01 → 2019-12-31	Cons.	Basic earnings loss per share (5-year summary)
EPS (basic)	¥7.77	2018-01-01 → 2018-12-31^d	Cons.	Basic earnings loss per share (5-year summary)
EPS (basic)	¥20.82	2017-01-01 → 2017-12-31^d	Cons.	Basic earnings loss per share (5-year summary)
EPS (basic)	¥9.75	2016-01-01 → 2016-12-31^d	Cons.	Basic earnings loss per share (5-year summary)
Net assets per share	¥336.41	at 2020-12-31	Cons.	Net assets per share (5-year summary)
Net assets per share	¥328.38	at 2019-12-31	Cons.	Net assets per share (5-year summary)
Net assets per share	¥315.65	at 2018-12-31^d	Cons.	Net assets per share (5-year summary)
Net assets per share	¥317.39	at 2017-12-31^d	Cons.	Net assets per share (5-year summary)
Net assets per share	¥302.5	at 2016-12-31^d	Cons.	Net assets per share (5-year summary)
Equity ratio	38.7%	at 2020-12-31	Cons.	Equity to asset ratio (5-year summary)
Equity ratio	37.6%	at 2019-12-31	Cons.	Equity to asset ratio (5-year summary)
Equity ratio	35.8%	at 2018-12-31^d	Cons.	Equity to asset ratio (5-year summary)
Equity ratio	35.2%	at 2017-12-31^d	Cons.	Equity to asset ratio (5-year summary)
Equity ratio	35.9%	at 2016-12-31^d	Cons.	Equity to asset ratio (5-year summary)
ROE	5.8%	2020-01-01 → 2020-12-31	Cons.	Rate of return on equity (5-year summary)
ROE	5.7%	2019-01-01 → 2019-12-31	Cons.	Rate of return on equity (5-year summary)
ROE	2.5%	2018-01-01 → 2018-12-31^d	Cons.	Rate of return on equity (5-year summary)
ROE	6.7%	2017-01-01 → 2017-12-31^d	Cons.	Rate of return on equity (5-year summary)
ROE	3.3%	2016-01-01 → 2016-12-31^d	Cons.	Rate of return on equity (5-year summary)
Employees	908	at 2020-12-31	Cons.	Number of employees
Employees	906	at 2019-12-31	Cons.	Number of employees
Employees	947	at 2018-12-31^d	Cons.	Number of employees
Employees	955	at 2017-12-31^d	Cons.	Number of employees
Employees	959	at 2016-12-31^d	Cons.	Number of employees
Revenue	¥2.5bn	2020-01-01 → 2020-12-31	Standalone	Net sales
Revenue	¥2.5bn	2019-01-01 → 2019-12-31	Standalone	Net sales
Revenue	¥2.6bn	2018-01-01 → 2018-12-31^d	Standalone	Net sales (5-year summary)
Revenue	¥2.5bn	2017-01-01 → 2017-12-31^d	Standalone	Net sales (5-year summary)
Revenue	¥2.6bn	2016-01-01 → 2016-12-31^d	Standalone	Net sales (5-year summary)
Operating income	¥1.1bn	2020-01-01 → 2020-12-31	Standalone	Operating income
Operating income	¥905m	2019-01-01 → 2019-12-31	Standalone	Operating income
Ordinary income	¥1.0bn	2020-01-01 → 2020-12-31	Standalone	Ordinary income
Ordinary income	¥853m	2019-01-01 → 2019-12-31	Standalone	Ordinary income
Ordinary income	¥625m	2018-01-01 → 2018-12-31^d	Standalone	Ordinary income loss (5-year summary)
Ordinary income	¥166m	2017-01-01 → 2017-12-31^d	Standalone	Ordinary income loss (5-year summary)
Ordinary income	¥394m	2016-01-01 → 2016-12-31^d	Standalone	Ordinary income loss (5-year summary)
Profit before tax	¥717m	2020-01-01 → 2020-12-31	Standalone	Income before income taxes
Profit before tax	¥1.1bn	2019-01-01 → 2019-12-31	Standalone	Income before income taxes
Net income	¥716m	2020-01-01 → 2020-12-31	Standalone	Profit loss
Net income	¥979m	2019-01-01 → 2019-12-31	Standalone	Profit loss
Net income	¥87m	2018-01-01 → 2018-12-31^d	Standalone	Net income loss (5-year summary)
Net income	¥85m	2017-01-01 → 2017-12-31^d	Standalone	Net income loss (5-year summary)
Net income	−¥507m	2016-01-01 → 2016-12-31^d	Standalone	Net income loss (5-year summary)
Total assets	¥33.4bn	at 2020-12-31	Standalone	Assets
Total assets	¥33.2bn	at 2019-12-31	Standalone	Assets
Total assets	¥33.3bn	at 2018-12-31^d	Standalone	Total assets (5-year summary)
Total assets	¥33.9bn	at 2017-12-31^d	Standalone	Total assets (5-year summary)
Total assets	¥32.8bn	at 2016-12-31^d	Standalone	Total assets (5-year summary)
Total liabilities	¥17.3bn	at 2020-12-31	Standalone	Liabilities
Total liabilities	¥16.9bn	at 2019-12-31	Standalone	Liabilities
Net assets / equity	¥16.2bn	at 2020-12-31	Standalone	Net assets
Net assets / equity	¥16.3bn	at 2019-12-31	Standalone	Net assets
Net assets / equity	¥15.9bn	at 2018-12-31^d	Standalone	Net assets
Net assets / equity	¥16.3bn	at 2017-12-31^d	Standalone	Net assets (5-year summary)
Net assets / equity	¥17.1bn	at 2016-12-31^d	Standalone	Net assets (5-year summary)
Cash and deposits	¥120m	at 2020-12-31	Standalone	Cash and deposits
Cash and deposits	¥145m	at 2019-12-31	Standalone	Cash and deposits
EPS (basic)	¥12.03	2020-01-01 → 2020-12-31	Standalone	Basic earnings loss per share (5-year summary)
EPS (basic)	¥16.21	2019-01-01 → 2019-12-31	Standalone	Basic earnings loss per share (5-year summary)
EPS (basic)	¥1.45	2018-01-01 → 2018-12-31^d	Standalone	Basic earnings loss per share (5-year summary)
EPS (basic)	¥1.42	2017-01-01 → 2017-12-31^d	Standalone	Basic earnings loss per share (5-year summary)
EPS (basic)	¥-8.09	2016-01-01 → 2016-12-31^d	Standalone	Basic earnings loss per share (5-year summary)
Dividend per share	¥7	2020-01-01 → 2020-12-31	Standalone	Dividend paid per share (5-year summary)
Dividend per share	¥7	2019-01-01 → 2019-12-31	Standalone	Dividend paid per share (5-year summary)
Dividend per share	¥7	2018-01-01 → 2018-12-31^d	Standalone	Dividend paid per share (5-year summary)
Dividend per share	¥7	2017-01-01 → 2017-12-31^d	Standalone	Dividend paid per share (5-year summary)
Dividend per share	¥7	2016-01-01 → 2016-12-31^d	Standalone	Dividend paid per share (5-year summary)
Net assets per share	¥272.03	at 2020-12-31	Standalone	Net assets per share (5-year summary)
Net assets per share	¥270.67	at 2019-12-31	Standalone	Net assets per share (5-year summary)
Net assets per share	¥262.74	at 2018-12-31^d	Standalone	Net assets per share (5-year summary)
Net assets per share	¥270.12	at 2017-12-31^d	Standalone	Net assets per share (5-year summary)
Net assets per share	¥275.82	at 2016-12-31^d	Standalone	Net assets per share (5-year summary)
Equity ratio	48.4%	at 2020-12-31	Standalone	Equity to asset ratio (5-year summary)
Equity ratio	49.1%	at 2019-12-31	Standalone	Equity to asset ratio (5-year summary)
Equity ratio	47.7%	at 2018-12-31^d	Standalone	Equity to asset ratio (5-year summary)
Equity ratio	48.1%	at 2017-12-31^d	Standalone	Equity to asset ratio (5-year summary)
Equity ratio	52.1%	at 2016-12-31^d	Standalone	Equity to asset ratio (5-year summary)
ROE	4.4%	2020-01-01 → 2020-12-31	Standalone	Rate of return on equity (5-year summary)
ROE	6.1%	2019-01-01 → 2019-12-31	Standalone	Rate of return on equity (5-year summary)
ROE	0.5%	2018-01-01 → 2018-12-31^d	Standalone	Rate of return on equity (5-year summary)
ROE	0.5%	2017-01-01 → 2017-12-31^d	Standalone	Rate of return on equity (5-year summary)
Shares issued	65,586,196	at 2020-12-31	Standalone	Total number of issued shares (5-year summary)
Shares issued	65,586,196	at 2019-12-31	Standalone	Total number of issued shares (5-year summary)
Shares issued	65,586,196	at 2018-12-31^d	Standalone	Total number of issued shares (5-year summary)
Shares issued	65,586,196	at 2017-12-31^d	Standalone	Total number of issued shares (5-year summary)
Shares issued	65,586,196	at 2016-12-31^d	Standalone	Total number of issued shares (5-year summary)
Employees	44	at 2020-12-31	Standalone	Number of employees
Employees	46	at 2019-12-31	Standalone	Number of employees
Employees	51	at 2018-12-31^d	Standalone	Number of employees
Employees	49	at 2017-12-31^d	Standalone	Number of employees
Employees	55	at 2016-12-31^d	Standalone	Number of employees

Periods use the dates stated in the filing. ^d = earlier-year period dated by calendar; ^v = that date confirmed by the company's own earlier filing.

Segments · 88

Segment	Item	Period	Value
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments	depreciation	2020-01-01 → 2020-12-31	¥0
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments	revenue	2020-01-01 → 2020-12-31	¥72m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments	revenue external	2020-01-01 → 2020-12-31	¥72m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments	segment assets	at 2020-12-31	¥58m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments	segment profit	2020-01-01 → 2020-12-31	¥13m
Reconciling Itemsreconciling	capex	2020-01-01 → 2020-12-31	¥558m
Reconciling Itemsreconciling	depreciation	2020-01-01 → 2020-12-31	¥220m
Reconciling Itemsreconciling	revenue	2020-01-01 → 2020-12-31	−¥9m
Reconciling Itemsreconciling	revenue intersegment	2020-01-01 → 2020-12-31	−¥9m
Reconciling Itemsreconciling	segment assets	at 2020-12-31	¥3.7bn
Enzymatic Medicinereportable segment	capex	2020-01-01 → 2020-12-31	¥141m
Enzymatic Medicinereportable segment	depreciation	2020-01-01 → 2020-12-31	¥246m
Enzymatic Medicinereportable segment	employees	at 2020-12-31	119 pure
Enzymatic Medicinereportable segment	revenue	2020-01-01 → 2020-12-31	¥3.3bn
Enzymatic Medicinereportable segment	revenue external	2020-01-01 → 2020-12-31	¥3.3bn
Enzymatic Medicinereportable segment	segment assets	at 2020-12-31	¥3.8bn
Enzymatic Medicinereportable segment	segment profit	2020-01-01 → 2020-12-31	¥591m
Liquorreportable segment	capex	2020-01-01 → 2020-12-31	¥937m
Liquorreportable segment	depreciation	2020-01-01 → 2020-12-31	¥1.2bn
Liquorreportable segment	employees	at 2020-12-31	717 pure
Liquorreportable segment	revenue	2020-01-01 → 2020-12-31	¥70.4bn
Liquorreportable segment	revenue external	2020-01-01 → 2020-12-31	¥70.4bn
Liquorreportable segment	revenue intersegment	2020-01-01 → 2020-12-31	¥9m
Liquorreportable segment	segment assets	at 2020-12-31	¥40.2bn
Liquorreportable segment	segment profit	2020-01-01 → 2020-12-31	¥1.3bn
Real Estatereportable segment	capex	2020-01-01 → 2020-12-31	¥8m
Real Estatereportable segment	depreciation	2020-01-01 → 2020-12-31	¥34m
Real Estatereportable segment	employees	at 2020-12-31	1 pure
Real Estatereportable segment	revenue	2020-01-01 → 2020-12-31	¥351m
Real Estatereportable segment	revenue external	2020-01-01 → 2020-12-31	¥351m
Real Estatereportable segment	segment assets	at 2020-12-31	¥1.7bn
Real Estatereportable segment	segment profit	2020-01-01 → 2020-12-31	¥186m
Starch For Processingreportable segment	capex	2020-01-01 → 2020-12-31	¥61m
Starch For Processingreportable segment	depreciation	2020-01-01 → 2020-12-31	¥62m
Starch For Processingreportable segment	employees	at 2020-12-31	29 pure
Starch For Processingreportable segment	revenue	2020-01-01 → 2020-12-31	¥3.6bn
Starch For Processingreportable segment	revenue external	2020-01-01 → 2020-12-31	¥3.6bn
Starch For Processingreportable segment	segment assets	at 2020-12-31	¥2.2bn
Starch For Processingreportable segment	segment profit	2020-01-01 → 2020-12-31	¥148m
—segment total	capex	2020-01-01 → 2020-12-31	¥1.1bn
—segment total	depreciation	2020-01-01 → 2020-12-31	¥1.5bn
—segment total	revenue	2020-01-01 → 2020-12-31	¥77.6bn
—segment total	revenue external	2020-01-01 → 2020-12-31	¥77.6bn
—segment total	revenue intersegment	2020-01-01 → 2020-12-31	¥9m
—segment total	segment assets	at 2020-12-31	¥47.9bn
—segment total	segment profit	2020-01-01 → 2020-12-31	¥2.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments	depreciation	2019-01-01 → 2019-12-31	¥0
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments	revenue	2019-01-01 → 2019-12-31	¥51m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments	revenue external	2019-01-01 → 2019-12-31	¥51m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments	segment assets	at 2019-12-31	¥40m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments	segment profit	2019-01-01 → 2019-12-31	¥13m
Reconciling Itemsreconciling	capex	2019-01-01 → 2019-12-31	¥270m
Reconciling Itemsreconciling	depreciation	2019-01-01 → 2019-12-31	¥153m
Reconciling Itemsreconciling	revenue	2019-01-01 → 2019-12-31	−¥13m
Reconciling Itemsreconciling	revenue intersegment	2019-01-01 → 2019-12-31	−¥13m
Reconciling Itemsreconciling	segment assets	at 2019-12-31	¥3.9bn
Enzymatic Medicinereportable segment	capex	2019-01-01 → 2019-12-31	¥211m
Enzymatic Medicinereportable segment	depreciation	2019-01-01 → 2019-12-31	¥209m
Enzymatic Medicinereportable segment	revenue	2019-01-01 → 2019-12-31	¥4.0bn
Enzymatic Medicinereportable segment	revenue external	2019-01-01 → 2019-12-31	¥4.0bn
Enzymatic Medicinereportable segment	segment assets	at 2019-12-31	¥3.9bn
Enzymatic Medicinereportable segment	segment profit	2019-01-01 → 2019-12-31	¥1.1bn
Liquorreportable segment	capex	2019-01-01 → 2019-12-31	¥2.4bn
Liquorreportable segment	depreciation	2019-01-01 → 2019-12-31	¥934m
Liquorreportable segment	revenue	2019-01-01 → 2019-12-31	¥67.4bn
Liquorreportable segment	revenue external	2019-01-01 → 2019-12-31	¥67.4bn
Liquorreportable segment	revenue intersegment	2019-01-01 → 2019-12-31	¥13m
Liquorreportable segment	segment assets	at 2019-12-31	¥41.2bn
Liquorreportable segment	segment profit	2019-01-01 → 2019-12-31	¥319m
Real Estatereportable segment	depreciation	2019-01-01 → 2019-12-31	¥21m
Real Estatereportable segment	revenue	2019-01-01 → 2019-12-31	¥340m
Real Estatereportable segment	revenue external	2019-01-01 → 2019-12-31	¥340m
Real Estatereportable segment	segment assets	at 2019-12-31	¥1.1bn
Real Estatereportable segment	segment profit	2019-01-01 → 2019-12-31	¥191m
Starch For Processingreportable segment	capex	2019-01-01 → 2019-12-31	¥2m
Starch For Processingreportable segment	depreciation	2019-01-01 → 2019-12-31	¥66m
Starch For Processingreportable segment	revenue	2019-01-01 → 2019-12-31	¥3.7bn
Starch For Processingreportable segment	revenue external	2019-01-01 → 2019-12-31	¥3.7bn
Starch For Processingreportable segment	segment assets	at 2019-12-31	¥2.4bn
Starch For Processingreportable segment	segment profit	2019-01-01 → 2019-12-31	¥136m
—segment total	capex	2019-01-01 → 2019-12-31	¥2.6bn
—segment total	depreciation	2019-01-01 → 2019-12-31	¥1.2bn
—segment total	revenue	2019-01-01 → 2019-12-31	¥75.4bn
—segment total	revenue external	2019-01-01 → 2019-12-31	¥75.4bn
—segment total	revenue intersegment	2019-01-01 → 2019-12-31	¥13m
—segment total	segment assets	at 2019-12-31	¥48.6bn
—segment total	segment profit	2019-01-01 → 2019-12-31	¥1.7bn
Liquorreportable segment	employees	at 2020-12-31	2 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,662

Item	Context	Value	Unit
Software	CurrentYearInstant	125000000	JPY
Other ia	Prior1YearInstant	183000000	JPY
Other ia	CurrentYearInstant	114000000	JPY
Intangible assets	Prior1YearInstant	406000000	JPY
Intangible assets	CurrentYearInstant	248000000	JPY
Investment securities	Prior1YearInstant	1630000000	JPY
Investment securities	CurrentYearInstant	1331000000	JPY
Long term prepaid expenses	Prior1YearInstant	125000000	JPY
Long term prepaid expenses	CurrentYearInstant	143000000	JPY
Deferred tax assets	Prior1YearInstant	895000000	JPY
Deferred tax assets	CurrentYearInstant	983000000	JPY
Net defined benefit asset	Prior1YearInstant	－	JPY
Net defined benefit asset	CurrentYearInstant	32000000	JPY
Other ioa	Prior1YearInstant	194000000	JPY
Other ioa	CurrentYearInstant	206000000	JPY
Allowance for doubtful accounts ioa by group	Prior1YearInstant	-5000000	JPY
Allowance for doubtful accounts ioa by group	CurrentYearInstant	-5000000	JPY
Investments and other assets	Prior1YearInstant	2840000000	JPY
Investments and other assets	CurrentYearInstant	2693000000	JPY
Noncurrent assets	Prior1YearInstant	26878000000	JPY
Noncurrent assets	CurrentYearInstant	26232000000	JPY
Assets	Prior1YearInstant	52568000000	JPY
Assets	CurrentYearInstant	51724000000	JPY
Notes and accounts payable trade	Prior1YearInstant	4868000000	JPY
Notes and accounts payable trade	CurrentYearInstant	4696000000	JPY
Electronically recorded obligations operating cl	Prior1YearInstant	1597000000	JPY
Electronically recorded obligations operating cl	CurrentYearInstant	1345000000	JPY
Short term loans payable	Prior1YearInstant	1050000000	JPY
Short term loans payable	CurrentYearInstant	1050000000	JPY
Lease obligations cl	Prior1YearInstant	16000000	JPY
Lease obligations cl	CurrentYearInstant	73000000	JPY
Accounts payable other	Prior1YearInstant	5000000000	JPY
Accounts payable other	CurrentYearInstant	4357000000	JPY
Accrued expenses	Prior1YearInstant	184000000	JPY
Accrued expenses	CurrentYearInstant	176000000	JPY
Accrued alcohol tax	Prior1YearInstant	8366000000	JPY
Accrued alcohol tax	CurrentYearInstant	8889000000	JPY
Accrued consumption taxes	Prior1YearInstant	677000000	JPY
Accrued consumption taxes	CurrentYearInstant	1729000000	JPY
Income taxes payable	Prior1YearInstant	167000000	JPY
Income taxes payable	CurrentYearInstant	552000000	JPY
Deposits received	Prior1YearInstant	320000000	JPY
Deposits received	CurrentYearInstant	330000000	JPY
Provision for bonuses	Prior1YearInstant	58000000	JPY
Provision for bonuses	CurrentYearInstant	58000000	JPY
Provision for directors bonuses	Prior1YearInstant	37000000	JPY
Provision for directors bonuses	CurrentYearInstant	40000000	JPY
Provision for shareholder benefit program cl	Prior1YearInstant	15000000	JPY
Provision for shareholder benefit program cl	CurrentYearInstant	18000000	JPY
Notes payable facilities	Prior1YearInstant	94000000	JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 24 of 24 passed

balance sheet identity	consolidated 2019-12-31	pass rounding
balance sheet identity	consolidated 2020-12-31	pass
balance sheet identity	non_consolidated 2019-12-31	pass
balance sheet identity	non_consolidated 2020-12-31	pass
dei present		pass
period resolution		pass
statement vs summary · net assets	consolidated 2018-12-31	pass
statement vs summary · net assets	consolidated 2019-12-31	pass
statement vs summary · net assets	consolidated 2020-12-31	pass
statement vs summary · net assets	non_consolidated 2018-12-31	pass
statement vs summary · net assets	non_consolidated 2019-12-31	pass
statement vs summary · net assets	non_consolidated 2020-12-31	pass
statement vs summary · net income attributable to parent	consolidated 2019-01-01/2019-12-31	pass
statement vs summary · net income attributable to parent	consolidated 2020-01-01/2020-12-31	pass
statement vs summary · operating cash flow	consolidated 2019-01-01/2019-12-31	pass
statement vs summary · operating cash flow	consolidated 2020-01-01/2020-12-31	pass
statement vs summary · revenue	consolidated 2019-01-01/2019-12-31	pass
statement vs summary · revenue	consolidated 2020-01-01/2020-12-31	pass
statement vs summary · revenue	non_consolidated 2019-01-01/2019-12-31	pass
statement vs summary · revenue	non_consolidated 2020-01-01/2020-12-31	pass
statement vs summary · total assets	consolidated 2019-12-31	pass
statement vs summary · total assets	consolidated 2020-12-31	pass
statement vs summary · total assets	non_consolidated 2019-12-31	pass
statement vs summary · total assets	non_consolidated 2020-12-31	pass